A065650 logo

Hyper Corporation Inc. Stock Price

KOSDAQ:A065650 Community·₩43.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A065650 Share Price Performance

₩3,240.00
-7560.00 (-70.00%)
₩3,240.00
-7560.00 (-70.00%)
Price ₩3,240.00

A065650 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Fair value with mediocre balance sheet.

3 Risks
1 Reward

Hyper Corporation Inc. Key Details

₩64.9b

Revenue

₩58.0b

Cost of Revenue

₩6.9b

Gross Profit

₩52.6b

Other Expenses

-₩45.7b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-3.43k
10.68%
-70.38%
94.9%
View Full Analysis

About A065650

Founded
1997
Employees
44
CEO
Hyun-Sang Muk
WebsiteView website
www.hyper-corp.com

Hyper Corporation Inc., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer's disease (AD) and neuropathic pain treatments, and AD diagnostics. Its products under development include TRPV1 Antagonist and TRPV1 Agonist for neuropathic pain; and anti-oligomerization of beta-amyloid, receptor for advanced glycation endproduct modulator, and early diagnosis kits for AD. The company wholesales and retails electronic devices, small home appliances, TVs, routers, and PC peripherals, such as gaming monitors, mouse, and wheels; keyboards; headsets; webcams; and sound bars, as well as provides online contents. In addition, it manufactures and supplies frozen and room temperature convenience food products, such as frozen sticky rice and fish cakes, tteokbokki sauce, and raw materials for sauce under the Memories of Elementary School Tteokbokki, Newtro, and K-TOWN brands. The company was formerly known as Medifron DBT Co., Ltd. and changed its name to Hyper Corporation Inc. in March 2024. Hyper Corporation Inc. was founded in 1997 and is headquartered in Seoul, South Korea.

Recent A065650 News & Updates

Recent updates

No updates